Is BSX or EW cheaper?

On trailing earnings, BSX is cheaper: BSX trades at a 18.58 P/E and EW at 48.29.

Which has grown faster, BSX or EW?

Over the past five years, BSX grew revenue faster — BSX at a 15.29% CAGR versus EW at 7.10%.

Is BSX or EW more profitable?

EW runs the higher net margin — BSX at 17.24% versus EW at 17.34%.

Which has been the better investment, BSX or EW?

Over the past 10-year, EW delivered the higher annualized total return — BSX at 7.05% versus EW at 10.98%. Past performance doesn't predict future results.

Boston Scientific Corporation (BSX) vs Edwards Lifesciences Corporation (EW)

BSX leads on 11 of 15 compared metrics.

A side-by-side comparison of Boston Scientific Corporation and Edwards Lifesciences Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 28, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

BSX

Boston Scientific Corporation

$65.74B

$44.23Healthcare

Edwards Lifesciences Corporation

$52.27B

$90.78Healthcare

Total return — BSX vs EW

growth of $100 · last 26y

BSX +303.2%EW +6502.2%EW compounded faster

Log scale — wide-divergence pair

BSX EW

BSX vs EW: by the numbers

•BSX is the larger company ($65.74B vs $52.27B market cap).
•BSX trades at the lower earnings multiple (18.58 vs 48.29 P/E).
•EW converts more revenue to profit (17.34% vs 17.24% net margin).
•BSX grew revenue faster over the past five years (15.29% vs 7.10% CAGR).

Which is better, BSX or EW?

Metric tally: BSX 11 · EW 4

It depends on what you're optimizing for:

ValueBSX(lower P/E)

GrowthBSX(faster 5Y revenue CAGR)

QualityEW(higher ROIC)

Metrics side by side

Valuation

Metric	BSX	EW
P/E ratio	18.58●	48.29
Forward P/E	11.89●	26.89
P/S ratio	3.21●	8.36
P/B ratio	2.56●	5.10
PEG ratio	0.88●	7.03
EV / EBITDA	13.65●	26.80
FCF yield	5.21%●	2.07%

Profitability

Metric	BSX	EW
Gross margin	70.41%	78.01%●
Operating margin	20.12%	27.62%●
Net margin	17.24%	17.34%
ROE	13.74%●	10.58%
ROIC	8.78%	11.40%●

Growth (annualized)

Metric	BSX	EW
Revenue CAGR (5Y)	15.29%●	7.10%
EPS CAGR (5Y)	-8.67%	6.87%●
FCF CAGR (5Y)	19.89%●	8.74%
Total return CAGR (5Y)	0.06%●	-2.60%

Frequently asked

Which is better, BSX or EW?: It depends on your goal. value: BSX (lower P/E); growth: BSX (faster 5Y revenue CAGR); quality: EW (higher ROIC). Across all compared metrics, BSX leads 11 to 4.
Is BSX or EW cheaper?: On trailing earnings, BSX is cheaper: BSX trades at a 18.58 P/E and EW at 48.29.
Which has grown faster, BSX or EW?: Over the past five years, BSX grew revenue faster — BSX at a 15.29% CAGR versus EW at 7.10%.
Is BSX or EW more profitable?: EW runs the higher net margin — BSX at 17.24% versus EW at 17.34%.
Which has been the better investment, BSX or EW?: Over the past 10-year, EW delivered the higher annualized total return — BSX at 7.05% versus EW at 10.98%. Past performance doesn't predict future results.

Go deeper

Full BSX analysis Full EW analysis Interactive comparison tool

Dig into the metrics

Boston Scientific P/E ratio Edwards Lifesciences P/E ratio Boston Scientific dividend yield Edwards Lifesciences dividend yield Boston Scientific ROE Edwards Lifesciences ROE Boston Scientific operating margin Edwards Lifesciences operating margin Boston Scientific revenue growth Edwards Lifesciences revenue growth Boston Scientific free cash flow Edwards Lifesciences free cash flow

Boston Scientific & Edwards Lifesciences appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 28, 2026.